154 related articles for article (PubMed ID: 23482537)
1. Inflammation in chronic venous ulcers.
Raffetto JD
Phlebology; 2013 Mar; 28 Suppl 1():61-7. PubMed ID: 23482537
[TBL] [Abstract][Full Text] [Related]
2. Dermal pathology, cellular biology, and inflammation in chronic venous disease.
Raffetto JD
Thromb Res; 2009; 123 Suppl 4():S66-71. PubMed ID: 19303508
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines.
Serra R; Grande R; Buffone G; Molinari V; Perri P; Perri A; Amato B; Colosimo M; de Franciscis S
Int Wound J; 2016 Feb; 13(1):53-8. PubMed ID: 24618232
[TBL] [Abstract][Full Text] [Related]
4. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
5. Venous ulcers--an evidence-based update.
Spear M
Plast Surg Nurs; 2012; 32(4):185-8. PubMed ID: 23188154
[TBL] [Abstract][Full Text] [Related]
6. Spatial distribution of mast cells in chronic venous leg ulcers.
Abd-El-Aleem SA; Morgan C; Ferguson MW; McCollum CN; Ireland GW
Eur J Histochem; 2005; 49(3):265-72. PubMed ID: 16216812
[TBL] [Abstract][Full Text] [Related]
7. Role of matrix metalloproteinases in non-healing venous ulcers.
Amato B; Coretti G; Compagna R; Amato M; Buffone G; Gigliotti D; Grande R; Serra R; de Franciscis S
Int Wound J; 2015 Dec; 12(6):641-5. PubMed ID: 24164799
[TBL] [Abstract][Full Text] [Related]
8. What's new: Management of venous leg ulcers: Approach to venous leg ulcers.
Alavi A; Sibbald RG; Phillips TJ; Miller OF; Margolis DJ; Marston W; Woo K; Romanelli M; Kirsner RS
J Am Acad Dermatol; 2016 Apr; 74(4):627-40; quiz 641-2. PubMed ID: 26979354
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of post-thrombotic syndrome.
Phillips LJ; Sarkar R
J Vasc Surg; 2007 Jun; 45 Suppl A():A116-22. PubMed ID: 17544032
[TBL] [Abstract][Full Text] [Related]
10. Surrogate endpoints for the treatment of venous leg ulcers.
Gelfand JM; Hoffstad O; Margolis DJ
J Invest Dermatol; 2002 Dec; 119(6):1420-5. PubMed ID: 12485449
[TBL] [Abstract][Full Text] [Related]
11. Venous ulcers of the lower extremity: Definition, epidemiology, and economic and social burdens.
Lal BK
Semin Vasc Surg; 2015 Mar; 28(1):3-5. PubMed ID: 26358303
[TBL] [Abstract][Full Text] [Related]
12. What's new: Management of venous leg ulcers: Treating venous leg ulcers.
Alavi A; Sibbald RG; Phillips TJ; Miller OF; Margolis DJ; Marston W; Woo K; Romanelli M; Kirsner RS
J Am Acad Dermatol; 2016 Apr; 74(4):643-64; quiz 665-6. PubMed ID: 26979355
[TBL] [Abstract][Full Text] [Related]
13. Potential role of metalloproteinase inhibitors from radiation‑sterilized amnion dressings in the healing of venous leg ulcers.
Litwiniuk M; Bikowska B; Niderla-Bielińska J; Jóźwiak J; Kamiński A; Skopiński P; Grzela T
Mol Med Rep; 2012 Oct; 6(4):723-8. PubMed ID: 22798012
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte and dermal vascular endothelial cell capacities remain unimpaired in the margin of chronic venous ulcer.
Galkowska H; Olszewski WL; Wojewodzka U
Arch Dermatol Res; 2005 Jan; 296(7):286-95. PubMed ID: 15565301
[TBL] [Abstract][Full Text] [Related]
15. Chronic venous ulcer: minimally invasive treatment of superficial axial and perforator vein reflux speeds healing and reduces recurrence.
Alden PB; Lips EM; Zimmerman KP; Garberich RF; Rizvi AZ; Tretinyak AS; Alexander JQ; Dorr KM; Hutchinson M; Isakson SL
Ann Vasc Surg; 2013 Jan; 27(1):75-83. PubMed ID: 23084734
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of venous leg ulcers can be better and cheaper. Annual costs calculation based on an inquiry study].
Tennvall GR; Andersson K; Bjellerup M; Hjelmgren J; Oien R
Lakartidningen; 2004 Apr; 101(17):1506-10, 1512-3. PubMed ID: 15150953
[TBL] [Abstract][Full Text] [Related]
17. Omics profiles in chronic venous ulcer wound fluid: innovative applications for translational medicine.
Mannello F; Ligi D; Canale M; Raffetto JD
Expert Rev Mol Diagn; 2014 Jul; 14(6):737-62. PubMed ID: 24918119
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers.
Harris IR; Yee KC; Walters CE; Cunliffe WJ; Kearney JN; Wood EJ; Ingham E
Exp Dermatol; 1995 Dec; 4(6):342-9. PubMed ID: 8608341
[TBL] [Abstract][Full Text] [Related]
19. The relationship between cytokine concentrations and wound healing in chronic venous ulceration.
Gohel MS; Windhaber RA; Tarlton JF; Whyman MR; Poskitt KR
J Vasc Surg; 2008 Nov; 48(5):1272-7. PubMed ID: 18771884
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of wound healing and alterations in venous leg ulcers-review.
Raffetto JD
Phlebology; 2016 Mar; 31(1 Suppl):56-62. PubMed ID: 26916770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
